MedWatch

GN chair promises delayed product launches in H1 2022

Per Wold-Olsen, chairman of GN Store Nord, says that GN Hearing is expecting to have previously postponed products ready for launch in the first half of 2022.

Per Wold-Olsen, chairman of the board of directors at GN Store Nord | Photo: Mik Eskestad/ERH

Back in October, GN Hearing had to downgrade its 2021 financial guidance considerably as two key product launches were delayed. Progress is now being made, and Chairman of GN Store Nord Per Wold-Olsen expects the products in question to hit the market in H1 2022, reports the Danish business daily Børsen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs